Demand growing for female condoms despite myths

Mary Beth Hastings, vice president of the Center for Health and Gender Equality (CHANGE), writes in the Huffington Post's "Impact" blog that despite "the pervasive myth that no one wants female condoms," "[d]emand is increasing because female condoms provide men and women with something they want: more options when it comes to protecting themselves." USAID officials "were surprised to hear evidence of an unmet demand for female condoms," Hastings says, adding, "[W]hen presented with evidence to the contrary, USAID started talking with different institutions about meeting the demand." She continues, "To its credit, the U.S. government is a global leader on female condoms. But there is still room for improvement."

Hastings says U.S.-funded HIV prevention and family planning programs "should all include education about and access to female condoms." She adds, "Female condoms are an opportunity to promote women's rights as much as they are an opportunity to fight HIV, because they can and they do generate important conversations within couples and communities about love, protection, trust and power," and concludes, "That's what makes them so special, and so worthy of investment" (11/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response